Schedule of warrant activity (Details) - Warrant [Member] - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of Warrants, Outstanding, Balance | 1,763,570 | |
| Weighted-Average Exercise Price, Outstanding, Beginning | $ 3.88 | |
| Weighted-Average Remaining Contractual Term, Outstanding | 2 years 1 month 6 days | 2 years 7 months 6 days |
| Aggregate Intrinsic Value, Outstanding, Beginning | ||
| Number of Warrants, Granted | ||
| Number of Warrants, Exercised | ||
| Number of Warrants, Outstanding, Balance | 1,763,570 | 1,763,570 |
| Weighted-Average Exercise Price, Outstanding, Ending | $ 3.88 | $ 3.88 |
| Aggregate Intrinsic Value, Outstanding, Ending | ||
| Number of Warrants, Exercisable | 1,763,570 | |
| Weighted-Average Exercise Price, Exercisable | $ 3.88 | |
| Weighted-Average Remaining Contractual Term, Exercisable | 2 years 1 month 6 days | |
| Aggregate Intrinsic Value, Exercisable |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options exercisable weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options outstanding weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Non Option Equity Instruments Exercisable Number. No definition available.
|
| X | ||||||||||
- Definition Non Options Exercisable Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non option aggregate intrinsic value outstanding. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non options aggregate intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|